Counterpressure Maneuvers for Fainting
Trial Summary
What is the purpose of this trial?
The investigators are interested in whether discrete counterpressure maneuvers, or muscle movements in the lower body, will boost blood pressure and cardiovascular control in children who faint. We will record cardiovascular responses to maneuvers of exaggerated sway, leg crossing, crouching, and gluteal muscle tensing in children who faint (N=20), as well as their height, weight, muscularity, and pubertal (Tanner) stage. Autonomic cardiovascular control will be measured using a Valsalva manoeuvre (expiration against a closed airway for 20 seconds) and a supine-stand test. The primary outcomes are noninvasive measures of cardiovascular responses to the maneuvers (blood pressure, cerebral blood flow, and stroke volume (volume of blood pumped per heartbeat). Comparisons will be made across levels of sex, diagnosis, Tanner stage, muscularity, height, and degree of autonomic control.
Do I need to stop my current medications to join the trial?
Yes, if you are taking any cardiovascular acting medications or medications for orthostatic syncope, you will be excluded from the study.
What data supports the idea that Counterpressure Maneuvers for Fainting is an effective treatment?
The available research does not provide any direct data supporting the effectiveness of Counterpressure Maneuvers for Fainting. The studies focus on muscle activation in different contexts, such as gluteus maximus activation during chair-rise in stroke patients or muscle activity during sit-to-stand movements. None of these studies directly address the use of Counterpressure Maneuvers for Fainting or compare it to other treatments for fainting.12345
What safety data exists for counterpressure maneuvers for fainting?
The provided research abstracts do not directly address the safety data for counterpressure maneuvers for fainting. They focus on muscle activation and contractility in various contexts, such as gluteal muscle contraction, abdominal muscle strength, and motor strategies for movements like sitting and squatting. None of these studies specifically evaluate the safety of counterpressure maneuvers or related techniques for fainting.14678
Research Team
Victoria E Claydon, PhD
Principal Investigator
Simon Fraser University
Eligibility Criteria
This trial is for English-speaking children aged 6-18 with recurrent fainting due to vasovagal syncope or POTS, having fainted at least twice in the last year. It excludes those not fully vaccinated against COVID-19, with seizure disorders, cardiovascular diseases, pregnancy, disabilities affecting test completion, on certain medications for syncope or heart issues.Inclusion Criteria
Exclusion Criteria
Timeline
Screening
Participants are screened for eligibility to participate in the trial
Testing Session
Participants attend a single testing session to perform various counterpressure maneuvers and cardiovascular tests.
Follow-up
Participants are monitored for any adverse effects or changes in cardiovascular responses post-testing.
Treatment Details
Interventions
- Baseline Stand
- Counterpressure Maneuvers
Find a Clinic Near You
Who Is Running the Clinical Trial?
Simon Fraser University
Lead Sponsor
Natural Sciences and Engineering Research Council, Canada
Collaborator
University of British Columbia
Collaborator
Provincial Health Services Authority
Collaborator